The Fas/Fas-ligand pathway does not mediate the apoptosis in elastase-induced emphysema in mice

Experimental Lung Research

Volumn 33, Issue 6, 2007, Pages 277-288

  Sawada, Masahiro ^a   Ohno, Yasushi ^a   La, Bu Lin Bai ^a   Funaguchi, Norihiko ^a   Asai, Toshihiro ^a   Yuhgetsu, Hideyuki ^a   Takemura, Genzou ^a   Minatoguchi, Shinya ^a   Fujiwara, Hisayoshi ^a   Fujiwara, Takako ^b  

^a GIFU UNIVERSITY   (Japan)

^b KYOTO WOMEN'S UNIVERSITY   (Japan)

Author keywords

Apoptosis; Emphysema; Fas Fas ligand pathway

Indexed keywords

ELASTASE; FAS LIGAND;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; EMPHYSEMA; HISTOLOGY; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; TRACHEOBRONCHIAL TOILET; WILD TYPE;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; BRONCHOALVEOLAR LAVAGE FLUID; CELL COUNT; DISEASE MODELS, ANIMAL; FAS LIGAND PROTEIN; IN SITU NICK-END LABELING; LUNG; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED MRL LPR; PANCREATIC ELASTASE; PULMONARY EMPHYSEMA; SIGNAL TRANSDUCTION; TIME FACTORS;

EID: 34547864628     PISSN: 01902148     EISSN: 15210499     Source Type: Journal    
DOI: 10.1080/01902140701509458     Document Type: Article

References (26)

1. Snider GL, Kleinerman J, Thurlbeck WM, Bengali ZH: The definition of emphysema. Report of a National Heart, Lung, and Blood Institute, Division of Lung Diseases workshop. Am Rev Respir Dis. 1985;132:182-185.
2. Demedts IK, Demoor T, Bracke KR, Joos GF, Brusselle GG: Role of apoptosis in the pathogenesis of COPD and pulmonary emphysema. Respir Res. 2006;7:53.
3. Kuwano K, Yoshimi M, Maeyama T, Hamada N, Yamada M, Nakanishi Y: Apoptosis signaling pathways in lung diseases. Med Chem. 2005;1:49-56.
4. Yokohori N, Aoshiba K, Nagai A: Increased levels of cell death and proliferation in alveolar wall cells in patients with pulmonary emphysema. Chest. 2004;125:626-632.
5. Imai K, Mercer BA, Schulman LL, Sonett JR, D'Armiento JM: Correlation of lung surface area to apoptosis and proliferation in human emphysema. Eur Respir J. 2005;25:250-258.
6. Segura-Valdez L, Pardo A, Gaxiola M, Uhal BD, Becerril C, Selman M: Upregulation of gelatinases A and B, collagenases 1 and 2, and increased parenchymal cell death in COPD. Chest. 2000;117:684-694.
7. Kasahara Y, Tuder RM, Cool CD, Lynch DA, Flores SC, Voelkel NF: Endothelial cell death and decreased expression of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 in emphysema. Am J Respir Crit Care Med. 2001;163(3 Pt 1):737-744.
8. Hodge S, Hodge G, Holmes M, Reynolds PN: Increased airway epithelial and T-cell apoptosis in COPD remains despite smoking cessation. Eur Respir J. 2005;25:447-454.
9. Yasuda N, Gotoh K, Minatoguchi S, Asano K, Nishigaki K, Nomura M, Ohno A, Watanabe M, Sano H, Kumada H, Sawa T, Fujiwara H: An increase of soluble Fas, an inhibitor of apoptosis, associated with progression of COPD. Respir Med. 1998;92:993-999.
10. Ma B, Kang MJ, Lee CG, Chapoval S, Liu W, Chen Q, Coyle AJ, Lora JM, Picarella D, Homer RJ, Elias JA: Role of CCR5 in IFN-gamma-induced and cigarette smoke-induced emphysema. J Clin Invest. 2005;115:3460-3472.
11. Adachi M, Watanabe-Fukunaga R, Nagata S: Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of lpr mice. Proc Natl Acad Sci USA. 1993;90:1756-1760.
12. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S: Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature. 1992;356:314-317.
13. Dunnill M: Quantitative methods in the study of pulmonary pathology. Thorax. 1962;17:320-328.
14. Thurlbeck WM: Internal surface area and other measurements in emphysema. Thorax. 1967;22:483-496.
15. Kasahara Y, Tuder RM, Taraseviciene-Stewart L, Le Cras TD, Abman S, Hirth PK, Waltenberger J, Voelkel NF: Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. J Clin Invest. 2000;106:1311-1319.
16. Aoshiba K, Yokohori N, Nagai A: Alveolar wall apoptosis causes lung destruction and emphysematous changes. Am J Respir Cell Mol Biol. 2003;28:555-562.
17. Petrache I, Natarajan V, Zhen L, Medler TR, Richter AT, Cho C, Hubbard WC, Berdyshev EV, Tuder RM: Ceramide upregulation causes pulmonary cell apoptosis and emphysema-like disease in mice. Nat Med. 2005;11:491-498.
18. Lucey EC, Keane J, Kuang PP, Snider GL, Goldstein RH: Severity of elastase-induced emphysema is decreased in tumor necrosis factor-alpha and interleukin-1beta receptor-deficient mice. Lab Invest. 2002;82:79-85.
19. Ding WX, Yin XM: Dissection of the multiple mechanisms of TNF-alpha-induced apoptosis in liver injury. J Cell Mol Med. 2004;8:445-454.
20. Huang Y, Erdmann N, Peng H, Zhao Y, Zheng J: The role of TNF related apoptosis-inducing ligand in neurodegenerative diseases. Cell Mol Immunol. 2005;2:113-122.
21. You RI, Chen MC, Wang HW, Chou YC, Lin CH, Hsieh SL: Inhibition of lymphotoxin-beta receptor-mediated cell death by survivin-Delta Ex3. Cancer Res. 2006;66:3051-3061.
22. Kuwano K, Hagimoto N, Kawasaki M, Yatomi T, Nakamura N, Nagata S, Suda T, Kunitake R, Maeyama T, Miyazaki H, Hara N: Essential roles of the Fas-Fas ligand pathway in the development of pulmonary fibrosis. J Clin Invest. 1999;104:13-19.
23. Kitamura Y, Hashimoto S, Mizuta N, Kobayashi A, Kooguchi K, Fujiwara I, Nakajima H: Fas=FasLdependent apoptosis of alveolar cells after lipopolysaccharide-induced lung injury in mice. Am J Respir Crit Care Med. 2001;163(3 Pt 1):762-769.
24. Hagimoto N, Kuwano K, Nomoto Y, Kunitake R, Hara N: Apoptosis and expression of Fas=Fas ligand mRNA in bleomycin-induced pulmonary fibrosis in mice. Am J Respir Cell Mol Biol. 1997;16:91-101.
25. Hagimoto N, Kuwano K, Miyazaki H, Kunitake R, Fujita M, Kawasaki M, Kaneko Y, Hara N: Induction of apoptosis and pulmonary fibrosis in mice in response to ligation of Fas antigen. Am J Respir Cell Mol Biol. 1997;17:272-278.
26. Matute-Bello G, Winn RK, Jonas M, Chi EY, Martin TR, Liles WC: Fas (CD95) induces alveolar epithelial cell apoptosis in vivo: implications for acute pulmonary inflammation. Am J Pathol 2001;158:153-161.